Guangdong Taienkang Pharmaceutical has a total of 425.5 Million outstanding shares. Guangdong Taienkang secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in stocks such as Guangdong Taienkang in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Guangdong Taienkang, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Guangdong
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Guangdong Taienkang Pharmaceutical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Guangdong Stock Ownership Analysis
About 50.0% of the company shares are owned by insiders or employees . The book value of Guangdong Taienkang was presently reported as 4.19. The company last dividend was issued on the 23rd of May 2024. Guangdong Taienkang had 1.8:1 split on the 29th of May 2023. For more info on Guangdong Taienkang Pharmaceutical please contact the company at 86 754 8884 7515 or go to https://www.tai-kang.com.cn.
Guangdong Taienkang Outstanding Bonds
Guangdong Taienkang issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Guangdong Taienkang uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Guangdong bonds can be classified according to their maturity, which is the date when Guangdong Taienkang Pharmaceutical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Guangdong Taienkang financial ratios help investors to determine whether Guangdong Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Guangdong with respect to the benefits of owning Guangdong Taienkang security.